Ponatinib - PDFSEARCH.IO - Document Search Engine

Ponatinib
Results: 34

#	Item
11	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG® (ponatinib) tablets for oral Add to Reading List Source URL: www.ariad.com Language: English - Date: 2014-10-07 13:49:25 Organochlorides Organofluorides Alkynes Ketorolac Syntex Ponatinib Clevidipine Dasatinib Chemistry Organic chemistry Piperazines
12	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG® (ponatinib) tablets for oral Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-07-25 12:30:45 Organochlorides Organofluorides Alkynes Ketorolac Syntex Ponatinib Clevidipine Dasatinib Chemistry Organic chemistry Piperazines
13	Ottobre[removed]Elenchi dei prodotti medicinali per le malattie rare in Europa* Add to Reading List Source URL: www.orpha.net Language: English - Date: 2014-11-03 09:45:01 Orphan drugs Medicine Ofatumumab Orphanet Ponatinib Dasatinib Leukemia Hyperammonemia Carglumic acid Chemistry Organic chemistry Piperazines
14	Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date: Add to Reading List Source URL: ahca.myflorida.com Language: English - Date: 2014-03-05 14:03:05 Pyrimidines Oncology Organofluorides Orphan drugs Myeloid leukemia Ponatinib Chronic myelogenous leukemia Philadelphia chromosome Dasatinib Organic chemistry Chemistry Piperazines
15	Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date: Add to Reading List Source URL: www.fdhc.state.fl.us Language: English - Date: 2014-03-05 14:03:05 Pyrimidines Oncology Organofluorides Orphan drugs Myeloid leukemia Ponatinib Chronic myelogenous leukemia Philadelphia chromosome Dasatinib Organic chemistry Chemistry Piperazines
16	Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date: Add to Reading List Source URL: www.ahca.myflorida.com Language: English - Date: 2014-03-05 14:03:05 Pyrimidines Oncology Organofluorides Orphan drugs Myeloid leukemia Ponatinib Chronic myelogenous leukemia Philadelphia chromosome Dasatinib Organic chemistry Chemistry Piperazines
17	CML, ALL, and B‐Cell Lymphomas: Understanding Professional Practice Gaps and Educational Needs among Hematologists and Medical Oncologists in the United States Add to Reading List Source URL: www.annenberg.net Language: English - Date: 2013-08-29 18:07:02 Pyrimidines Medicine Orphan drugs Organofluorides Pyridines Ponatinib Chronic myelogenous leukemia Dasatinib Nilotinib Organic chemistry Chemistry Piperazines
18	ASCO ANSWER S C H RO N I C M Y E LO I D L E U K E M I A Illustration by Robert Morreale/Visual Explanations, LLC. © 2004 American Society of Clinical Oncology. WHAT IS CHRONIC MYELOID LEUKEMIA? Chronic myeloid leukemia Add to Reading List Source URL: www.cancer.net Language: English - Date: 2013-11-01 16:15:03 Myeloid leukemia Chronic myelogenous leukemia Ponatinib Philadelphia chromosome Hematological malignancy Leukemia Hematopoietic stem cell transplantation Imatinib Chemotherapy Medicine Oncology Piperazines
19	PRESSEMITTEILUNG 50. Erstattungsbetrag erfolgreich verhandelt Berlin, [removed]: Mit Ponatinib (Handelsname Iclusig ) vom Hersteller ARIAD ® Pharmaceuticals liegt der 50. Erstattungsbetrag vor, der nach den Kriterien Add to Reading List Source URL: www.gkv-spitzenverband.de Language: German - Date: 2014-08-29 19:00:33
20	CDER New Molecular Entity (NME) & New BLA Calendar Year Approvals As of December 31, 2012 Selection Criteria: User Response: Start Date: [removed] Add to Reading List Source URL: www.fda.gov Language: English Benzamides Piperazines Orphan drugs Organofluorides Kidney cancer Ponatinib Omacetaxine mepesuccinate Chronic myelogenous leukemia Renal cell carcinoma Medicine Oncology Chemistry

UPDATE